关注
Yanqin Huang
Yanqin Huang
Beth Israel Deaconess Medical Center, Harvard Medical School
在 fudan.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Therapeutic options for metallo-β-lactamase-producing enterobacterales
X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences, N Singh, ...
Infection and drug resistance, 125-142, 2021
852021
Design, synthesis, and structure–activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents
C Ling, L Fu, S Gao, W Chu, H Wang, Y Huang, X Chen, Y Yang
Journal of Medicinal Chemistry 57 (11), 4772-4795, 2014
782014
Design, synthesis, and structure–activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents
Q Xin, H Fan, B Guo, H He, S Gao, H Wang, Y Huang, Y Yang
Journal of medicinal chemistry 54 (21), 7493-7502, 2011
562011
Solubility-driven optimization of (pyridin-3-yl) benzoxazinyl-oxazolidinones leading to a promising antibacterial agent
B Guo, H Fan, Q Xin, W Chu, H Wang, Y Huang, X Chen, Y Yang
Journal of Medicinal Chemistry 56 (6), 2642-2650, 2013
512013
Isolation and phylogenetic analysis of the biologically active bacteria associated with three South China Sea sponges
ZY Li, Y Hu, YQ Huang, Y Huang
Microbiology 76 (4), 494-499, 2007
342007
Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020
N Singh, L Poggensee, Y Huang, CT Evans, KJ Suda, ZP Bulman
JAC-Antimicrobial Resistance 4 (3), dlac049, 2022
212022
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae
Y Huang, AP Rana, E Wenzler, EA Ozer, F Krapp, JB Bulitta, AR Hauser, ...
Journal of Antimicrobial Chemotherapy 77 (2), 356-363, 2022
202022
Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I
Y Huang, Y Xu, S Liu, H Wang, X Xu, Q Guo, B Wu, MF Gordeev, W Wang, ...
International journal of antimicrobial agents 43 (5), 418-422, 2014
202014
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib
DA Butler, AP Rana, F Krapp, SR Patel, Y Huang, EA Ozer, AR Hauser, ...
Journal of Antimicrobial Chemotherapy 76 (3), 671-679, 2021
162021
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
Y Huang, K Sokolowski, A Rana, N Singh, J Wang, K Chen, Y Lang, ...
Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00692-21, 2021
132021
细薄星芒海绵中活性菌筛选及混合菌协同效应
黄艳琴, 李志勇, 蒋群, 乔雨, 李堃宝
微生物学通报 32 (4), 5-10, 2005
122005
贪婪倔海绵中抗菌活性细菌的筛选及初步鉴定
沈颖, 李志勇, 蒋群, 黄艳琴, 何丽明
微生物学通报 32 (4), 15-19, 2005
92005
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
M Wences, ER Wolf, C Li, N Singh, N Bah, X Tan, Y Huang, ZP Bulman
Antibiotics 11 (7), 959, 2022
82022
海绵中可培养与原位微生物组成的 DGGE 指纹分析
何丽明, 李志勇, 蒋群, 黄艳琴
微生物学通报 32 (3), 51-56, 2005
82005
In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
Y Huang, T Wu, O Perez, AP Rana, L Chen, BN Kreiswirth, MJ Satlin, ...
Frontiers in Microbiology 12, 618087, 2021
72021
Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids
ZP Bulman, X Tan, TY Chu, Y Huang, AP Rana, N Singh, SA Flowers, ...
Computational and Structural Biotechnology Journal 20, 3946-3954, 2022
52022
Therapeutic options for Metallo-β-Lactamase producing Enterobacterales. Infect Drug Resist 14: 125–142
X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences, N Singh, ...
52021
Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01
C Shao, W Zhou, S Zhang, W Wei, L Ruan, Y Jin, X Sun, Y Huang
Bioorganic & medicinal chemistry letters 21 (22), 6732-6738, 2011
52011
Therapeutic options for metallo-β-lactamase-producing Enterobacterales. Infect Drug Resist 2021; 14: 125–42
X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences
5
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy
JR Lenhard, AP Rana, E Wenzler, Y Huang, BN Kreiswirth, L Chen, ...
Diagnostic microbiology and infectious disease 98 (1), 115080, 2020
32020
系统目前无法执行此操作,请稍后再试。
文章 1–20